Effect of SBRT plus immunotherapy on immune status and survival quality of NSCLC patients: A study of combined radiotherapy and immunotherapy
SBRT plus immunotherapy can reduce the level of various tumor markers, improve the immune status and quality of survival for NSCLC patients.
Authors
- Mimi Jiang
- Mengdan Yang
- Dan Zhang (ORCID: https://orcid.org/0000-0002-2496-4483)
- Hongfeng Li (ORCID: https://orcid.org/0000-0003-3959-155X)
- Liang Shao (ORCID: https://orcid.org/0000-0001-9066-8503)
- Yanting Yan
- Ying Gao (ORCID: https://orcid.org/0000-0003-1755-8003)
Institutions
- General Hospital of Shenyang Military Region (CN)
Publication Details
- Journal
- Technology and Health Care
- Published
- 2024-08-20
- DOI
- https://doi.org/10.3233/thc-241177
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.28